Free Trial

Merck KGaA (MKKGY) Expected to Announce Earnings on Wednesday

Merck KGaA logo with Medical background

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) is projected to release its earnings data on Wednesday, May 21st. Analysts expect Merck KGaA to post earnings of $0.50 per share and revenue of $5.32 billion for the quarter.

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) last released its quarterly earnings results on Thursday, March 6th. The company reported $0.54 EPS for the quarter, beating analysts' consensus estimates of $0.47 by $0.07. The firm had revenue of $5.78 billion for the quarter, compared to analyst estimates of $5.40 billion. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%. On average, analysts expect Merck KGaA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Merck KGaA Price Performance

OTCMKTS:MKKGY opened at $28.37 on Wednesday. The firm has a market cap of $18.33 billion, a PE ratio of 17.51, a price-to-earnings-growth ratio of 2.05 and a beta of 0.96. Merck KGaA has a 12 month low of $24.32 and a 12 month high of $39.17. The company's 50-day moving average price is $27.56 and its two-hundred day moving average price is $29.04. The company has a quick ratio of 0.91, a current ratio of 1.33 and a debt-to-equity ratio of 0.28.

Merck KGaA Increases Dividend

The firm also recently declared a dividend, which was paid on Wednesday, May 7th. Investors of record on Wednesday, April 30th were given a dividend of $0.3382 per share. The ex-dividend date of this dividend was Tuesday, April 29th. This is a positive change from Merck KGaA's previous dividend of $0.32. This represents a yield of 1.25%. Merck KGaA's dividend payout ratio is 17.65%.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Recommended Stories

Earnings History for Merck KGaA (OTCMKTS:MKKGY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines